IB COMMUNICATIONS PRESS RELEASES

Kansas City, MO, April 22, 2025 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, announced a new peer-reviewed publication that demonstrates a promising improvement in the effort to develop liver cell-based therapies for patients with....

LAKEWOOD, Colorado, — April 16, 2025 — Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the addition of Patrick Daly as its Chief Business Officer as the company continues to expand its capabilities to meet evolving market segments. Daly joins Terumo BCT with over 30 years of business and healthcare industry experience....

London, UK, April 7, 2025 – Phacilitate is pleased to announce that registration is now open for Advanced Therapies Europe 2025, 2–4 September at the Hotel Arts, Ritz-Carlton, in Barcelona, one of Europe’s fastest-growing biotech hubs. This exclusive gathering brings together 500 pre-approved leaders from across the advanced therapies ecosystem for three days of high-impact content, curated networking and strategic deal-making.

Phoenix, AZ, April 2, 2025 – Title21 Health Solutions, the software innovators for meeting life science regulatory needs, announced the addition of Jonathan Wofford as the company’s first Chief Commercial Officer (CCO) to oversee the company’s products, sales, and marketing efforts. Wofford has over two decades of experience in the cell therapy and stem....

Mulhouse, France, March 27, 2025 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, named its new Board of Directors led by co-founder Jérôme Koch, in line with recent bridge financing organized among shareholders and new investors. The new board features both investors and independent members, with a wealth....

Lakewood, Colorado, March 18, 2025 – Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, signed a memorandum of understanding (MOU) with Osong Medical Innovation Foundation (KBIOHealth) toward joint development of workforce training for cell and gene therapy (CGT) manufacturing. The partners will begin

London, UK; March 14, 2025 - IB Communications, an international media relations and public strategy firm, and Terrapinn, a global company whose events promote innovation and technology that changes people’s lives, today announce a partnership to increase audience reach of the life sciences community for the content for Advanced Therapies UK 2025....

Kansas City, MO, March 12, 2025 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, announced a new grant from the Gates Foundation that supports the company’s proprietary Core-Shell Spherification® (CSS®) system to extend th....

Rome, Italy – March 12 2025 – ReiThera, a global Contract Development and Manufacturing Organization (CDMO), is highlighting its latest vector platform, ReiCell-AAV, alongside the rest of its comprehensive portfolio at Advanced Therapies 2025 in London. ReiCell-AAV enables scalable production of AAVs, the most common vector used in commercial....

Mulhouse, France, March 11, 2025 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced it will be presenting next week at Terrapinn’s Advanced Therapies Congress 2025, held in London. Ibon Garitaonandia, PhD, MBA, Chief Scientific Officer, will present on “Development of cell-based therapies for Post-acute .....

Barcelona, Spain – 5 March 2025 – Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders, today announces that the first patient in the TREE study has been dosed with leriglitazone. TREE is a phase 2a clinical study assessing the safety and efficacy of lead candidate leriglitazone, a novel, brain-penetrant and selective PPAR gamma agonist, to treat patients with Rett syndrome.

Chicago, IL, February 26, 2025 – Pragmatrix Technology (“Pragmatrix”), a pioneer in SaaS solutions for the cell therapy industry, proudly announces its partnership with Achieve Clinics (“Achieve”), a Los Angeles, California biotechnology company dedicated to improving patient access to autologous cell therapies. A customized version of PragLife, Pragmatrix’s flagship platform, will now be implemented to support Achieve Clinics' operations end-to-end.

Lakewood, Colorado, February 25, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced a partnership with the nonprofit National Alliance of Sickle Cell Centers (NASCC) that aims to improve the lives of people with sickle cell disease (SCD) by addressing gaps in access to blood transfusion therapy and helping....

Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and....

Lakewood, Colorado, January 29, 2025 – Terumo Blood and Cell Technologies, a global leader in blood management solutions, today announces that Carter BloodCare is the first U.S. adopter of its Reveos™ Automated Blood Processing System and Lumia™ Software Platform. Carter BloodCare, one of the largest Texas blood centers, is the first to begin....

Rome, Italy January 24th 2025 – ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.....

London, UK, January 22, 2025 – Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with its prestigious Lifetime Achievement Award for 2025. Dr. High, who is now President of Therapeutics at AskBio, has had....

Lakewood, Colorado, January 21, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, believes the future of medicine begins with a single drop of blood. From lifesaving blood transfusions to novel personalized therapies, blood and cells are the foundation of healthcare innovation......

January 21 2025 – SOMERSET, NJ – Catalent, Inc., a leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic  collaboration with Galapagos NV (Euronext & NASDAQ: GLPG), a biotechnology company with operations in the U.S. and Europe, to support decentralized manufacturing for clinical studies....

Lakewood, COLO. AND SANTA ANA, CALIF., January 14, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System. By using systems that work together, this collaboration offers an optimized workflow solution with a ready-to-use process, aimed at reducing the barriers in scaling T cell expansion.